See more : Hemogenyx Pharmaceuticals Plc (HOPHF) Income Statement Analysis – Financial Results
Complete financial analysis of Alkuri Global Acquisition Corp. (KURIW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Alkuri Global Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Sparinvest SICAV – European Value (SSIEUVEURR.CO) Income Statement Analysis – Financial Results
- TNF Pharmaceuticals, Inc. (TNFA) Income Statement Analysis – Financial Results
- Unimicron Technology Corp. (3037.TW) Income Statement Analysis – Financial Results
- Huntington Bancshares Incorporated (HBAN) Income Statement Analysis – Financial Results
- Autoneum Holding AG (AUTN.SW) Income Statement Analysis – Financial Results
Alkuri Global Acquisition Corp. (KURIW)
Industry: Shell Companies
Sector: Financial Services
About Alkuri Global Acquisition Corp.
ARK Global Acquisition Corp., a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in Nashville, Tennessee.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 1.11B | 320.83M | 79.27M | 16.03M |
| Cost of Revenue | 1.13B | 111.74M | 108.79M | 19.81M |
| Gross Profit | -17.86M | 209.09M | -29.52M | -3.78M |
| Gross Profit Ratio | -1.61% | 65.17% | -37.24% | -23.55% |
| Research & Development | 79.16M | 68.47M | 54.71M | 51.21M |
| General & Administrative | 0.00 | 165.87M | 86.07M | 68.90M |
| Selling & Marketing | 0.00 | 9.98M | 6.58M | 7.69M |
| SG&A | 227.94M | 187.17M | 91.28M | 76.59M |
| Other Expenses | 44.81M | -46.53M | 0.00 | 0.00 |
| Operating Expenses | 351.90M | 302.18M | 145.99M | 159.04M |
| Cost & Expenses | 1.48B | 413.92M | 254.78M | 178.85M |
| Interest Income | 1.04M | 325.00K | 610.00K | 1.02M |
| Interest Expense | 32.74M | 13.05M | 4.03M | 1.12M |
| Depreciation & Amortization | 12.05M | 9.19M | 14.49M | 2.50M |
| EBITDA | -176.73M | -62.65M | -161.02M | -159.31M |
| EBITDA Ratio | -15.93% | -26.15% | -203.13% | -993.57% |
| Operating Income | -369.75M | -93.09M | -175.51M | -162.82M |
| Operating Income Ratio | -33.32% | -29.02% | -221.40% | -1,015.47% |
| Total Other Income/Expenses | 148.24M | 11.55M | -6.76M | 16.97M |
| Income Before Tax | -221.52M | -81.54M | -182.27M | -145.85M |
| Income Before Tax Ratio | -19.96% | -25.42% | -229.93% | -909.60% |
| Income Tax Expense | -66.00K | -1.44M | 4.64M | -5.56M |
| Net Income | -221.45M | -77.41M | -186.80M | -140.29M |
| Net Income Ratio | -19.96% | -24.13% | -235.64% | -874.93% |
| EPS | -12.01 | -173.26 | -108.29 | -1.51 |
| EPS Diluted | -12.01 | -173.26 | -108.29 | -1.51 |
| Weighted Avg Shares Out | 18.44M | 446.77K | 1.73M | 92.85M |
| Weighted Avg Shares Out (Dil) | 18.44M | 446.77K | 1.73M | 92.85M |
Source: https://incomestatements.info
Category: Stock Reports